MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278.
The pediatric cancer research program is an integral component of the renowned University of Chicago Medicine Comprehensive Cancer Center. This National Cancer Institute-designated Comprehensive Cancer Center, one of only two in Illinois, comprises an outstanding and extensive team of laboratory scientists, caregivers, clinical researchers and trainees who work together to unlock the mysteries behind all types of cancer and to develop solutions to the complexity of individual cancers. More than 50 of our current investigators — funded by federal, state and philanthropic sources — have made key discoveries that advanced the understanding of the diagnosis and treatment of leukemia. Over a 40-year time span, the comprehensive and collaborative nature of UChicago Medicine's Comprehensive Cancer Center has allowed several major advances in the diagnosis and treatment of leukemia including:
Ongoing research continues the quest to understand leukemia and other cancers with the goal of discerning new and better treatments for the disease. Recent grants for leukemia research are currently funding:
At any given time, we offer more than 30 clinical trials for the treatment of leukemia. These include first line therapies, therapies for children with refractory or relapsed leukemias, stem cell transplantation strategies and new phase I drugs for leukemia.
Our pediatric cancer researchers are also members — and often leaders — of many national and international cancer research groups including:
These partnerships and collaborations further our ability to bring the latest treatment innovations from the laboratory bench to the patient bedside as quickly as possible.